Sentences with phrase «markets purchase more shares»

Investors savvy enough to reinvest dividends during bear markets purchase more shares with the dividend while the prices are low rather than when the prices are high.

Not exact matches

And the company could theoretically pull off such a purchase; the share price of Netflix has nosedived more than 60 % since its high in July, with a corresponding reduction in market cap.

And more shares could be released if banking underwriters exercise their option to purchase additional shares (an option all banks retain when guiding a company to the public market).

These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).

(d) by causing Retrophin to pay cash to himself, Biestek, and Fernandez so that he would not have to invest $ 731,778 of his own funds in the February PIPE, and by using PIPE proceeds in contravention of the terms of the Securities Purchase Agreement to fund investments by Shkreli, Biestek and Fernandez, resulting in an additional benefit to Shkreli alone of $ 360,000 in cash and 180,000 Retrophin shares and warrants worth more than $ 5.3 million (at current market prices).

This is because reinvested dividends during crashes and market corrections purchase more cheap shares that will, in the future, generate far higher profits when the market rebounds.

No participant will have the right to purchase shares of our Class A common stock in an amount, when aggregated with purchase rights under all our employee stock purchase plans that are also in effect in the same calendar year, that have a fair market value of more than $ 25,000, determined as of the first day of the applicable purchase period, for each calendar year in which that right is outstanding.

However, a participant may not purchase more than shares in each offering period and may not subscribe for more than $ 25,000 in fair market value of shares of our common stock (determined at the time the option is granted) during any calendar year.

Nonstatutory Stock Options, or NSOs, will provide for the right to purchase shares of our common stock at a specified price, which may not be less than fair market value on the date of grant, and usually will become exercisable (at the discretion of the administrator) in one or more installments after the grant date, subject to the participant's continued employment or service with us and / or subject to the satisfaction of corporate performance targets and individual performance targets established by the administrator.

«The later stages of the 2009 — 2017 bull market are a valuation illusion built on share buyback alchemy... The technique optically reduces the price - to - earnings multiple because the denominator doesn't adjust for the reduced share count... Share buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare buyback alchemy... The technique optically reduces the price - to - earnings multiple because the denominator doesn't adjust for the reduced share count... Share buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare count... Share buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grShare buybacks are a major contributor to the low volatility regime because a large price insensitive buyer is always ready to purchase the market on weakness... Share buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grShare buybacks result in a lower volatility, lower liquidity, which in turn incentivizes more share buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare buybacks, further incentivizing passive and systematic strategies that are short volatility in all their forms... Like a snake eating its own tail, the market can not rely on share buybacks indefinitely to nourish the illusion of grshare buybacks indefinitely to nourish the illusion of growth.

Whereas purchasing more shares from the secondary market has no effect on the company itself.

In this case, DCA let me purchase more and more shares as the market kept going down until March when it started to rebound.

You can see that yes, more shares can be purchased because of the drop in market price.

The reason is that all three categories are in a bull market for some time and every time you made a purchase, the shares were likely to be more expensive than what you paid last time.

In fact, if you are dollar cost averaging by adding to your savings each paycheck as most people do, then you are actually better off when there is a market downturn, since you are able to purchase more shares.

If its worth so much more than the market price might he not just step up and purchase all the remaining shares at even a 10 % discount to his estimate of intrinsic value?

I'm hoping the market doesn't pump up the value of the shares too much before I can get myself to look more closely at the two stand alone companies (already up 7 + % since I purchased, ouch!)

In sum, I still believe there is more value in ENZN shares than Mr. Market is currently reflecting, though nowhere near what I expected when I originally purchased.

You can bail out of your stock - market investments, as many investors do during steep market declines, or use these declines as an opportunity to purchase more shares at lower prices, through monthly portfolio contributions or timely rebalancing from bonds to stocks.

If you invest money on a regular basis to purchase shares, bear markets allow the same invested amount to buy more shares, bull markets mean you'll purchase fewer shares.

When the markets are down, the situation is reversed, and you purchase more shares per dollar invested.

While dollar - cost averaging won't insulate you from losses or guarantee a profit in a volatile market, investors will purchase more shares when prices are lower, and fewer when they are higher.

Therefore, CSIM typically supports employee stock purchase plans when the shares can be purchased at 85 % or more of the shares» market value.

Sharing these good works with retailers provides the tools for salespeople to assure consumers that these purchases will not only work to create a more enjoyable home environment, but also support activities that benefit the planet, as outlined by Ted Morgan director of marketing at Biokleen, maker of Bac - Out.

It is a close second in online sales to Rakuten according to 2016 market share estimates and U.S. data show Amazon Echo owners spend 10 % more after purchasing an Alexa - enabled device.

The flash sales & other online sales are not 100 % done by consumers because there's again a major share held by offline retailers who purchase these online exclusive phones & sell them at a premium, ultimately proving that the online purchases are still are a far away and brands should be focusing more on making their products available in the offline markets.

The plan states that if a person or group buys more than 15 percent of the company's outstanding shares, the remaining Ramco - Gershenson shareholders will have the right to purchase additional shares with a market value of twice the purchase price paid by the original bidder.

Highest - Yielding Zip Codes in Atlanta, Houston, Central Florida and Dallas; Institutional Investor Purchase Share Down Nationwide, Up in 37 Percent of Zip Codes; IRVINE, Calif. — Oct. 19, 2017 — ATTOM Data Solutions, curator of the nation's largest multi-sourced property database, today released its Q3 2017 Single Family Rental Market report, which identified the top... Read More»